229 related articles for article (PubMed ID: 28440019)
1. Cervical cancer risk and impact of Pap-based screening in HIV-positive women on antiretroviral therapy in Johannesburg, South Africa.
Rohner E; Sengayi M; Goeieman B; Michelow P; Firnhaber C; Maskew M; Bohlius J
Int J Cancer; 2017 Aug; 141(3):488-496. PubMed ID: 28440019
[TBL] [Abstract][Full Text] [Related]
2. Cervical cancer risk in women living with HIV across four continents: A multicohort study.
Rohner E; Bütikofer L; Schmidlin K; Sengayi M; Maskew M; Giddy J; Taghavi K; Moore RD; Goedert JJ; Gill MJ; Silverberg MJ; D'Souza G; Patel P; Castilho JL; Ross J; Sohn A; Bani-Sadr F; Taylor N; Paparizos V; Bonnet F; Verbon A; Vehreschild JJ; Post FA; Sabin C; Mocroft A; Dronda F; Obel N; Grabar S; Spagnuolo V; Quiros-Roldan E; Mussini C; Miro JM; Meyer L; Hasse B; Konopnicki D; Roca B; Barger D; Clifford GM; Franceschi S; Egger M; Bohlius J
Int J Cancer; 2020 Feb; 146(3):601-609. PubMed ID: 31215037
[TBL] [Abstract][Full Text] [Related]
3. Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.
Bohlius J; Valeri F; Maskew M; Prozesky H; Garone D; Sengayi M; Fox MP; Davies MA; Egger M
Int J Cancer; 2014 Dec; 135(11):2644-52. PubMed ID: 24729433
[TBL] [Abstract][Full Text] [Related]
4. Incidence and predictors of sexually transmitted infections among adult HIV-positive patients receiving antiretroviral therapy at Themba Lethu HIV clinic in Johannesburg, South Africa.
Onoya D; Manjengwa P; Nattey C; Kgowedi S; Mbele M; Shumba K; Fox MP
S Afr Med J; 2020 Dec; 111(1):80-86. PubMed ID: 33404011
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, incidence, predictors, treatment, and control of hypertension among HIV-positive adults on antiretroviral treatment in public sector treatment programs in South Africa.
Brennan AT; Jamieson L; Crowther NJ; Fox MP; George JA; Berry KM; Stokes A; Maskew M; Sanne I; Long L; Cassim N; Rosen S
PLoS One; 2018; 13(10):e0204020. PubMed ID: 30281618
[TBL] [Abstract][Full Text] [Related]
6. Mapping the cervical cancer screening cascade among women living with HIV in Johannesburg, South Africa
Rohner E; Mulongo M; Pasipamire T; Oberlin AM; Goeieman B; Williams S; Lubeya MK; Rahangdale L; Chibwesha CJ
Int J Gynaecol Obstet; 2021 Jan; 152(1):53-59. PubMed ID: 33188707
[TBL] [Abstract][Full Text] [Related]
7. Integrating Cervical Cancer Screening Into Safer Conception Services to Improve Women's Health Outcomes: A Pilot Study at a Primary Care Clinic in South Africa.
Davies NECG; Chersich M; Mullick S; Naidoo N; Makhoba N; Rees H; Schwartz SR
Sex Transm Dis; 2019 Feb; 46(2):91-97. PubMed ID: 30308532
[TBL] [Abstract][Full Text] [Related]
8. Incidence rate of Kaposi sarcoma in HIV-infected patients on antiretroviral therapy in Southern Africa: a prospective multicohort study.
Rohner E; Valeri F; Maskew M; Prozesky H; Rabie H; Garone D; Dickinson D; Chimbetete C; Lumano-Mulenga P; Sikazwe I; Wyss N; Clough-Gorr KM; Egger M; Chi BH; Bohlius J
J Acquir Immune Defic Syndr; 2014 Dec; 67(5):547-54. PubMed ID: 25393941
[TBL] [Abstract][Full Text] [Related]
9. Impact of HIV infection on access to cancer care and survival among women with invasive cervical cancer in Côte d'Ivoire: A prospective cohort study.
Boni SP; Horo A; Didi-Kouko-Coulibaly J; Tanon A; Tchounga BK; Coffie PA; Comoe JC; Moh RD; Dabis F; Adoubi I; Jaquet A;
Int J Gynaecol Obstet; 2023 Nov; 163(2):392-401. PubMed ID: 37350012
[TBL] [Abstract][Full Text] [Related]
10. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community.
Gupta A; Wood R; Kaplan R; Bekker LG; Lawn SD
PLoS One; 2012; 7(3):e34156. PubMed ID: 22479548
[TBL] [Abstract][Full Text] [Related]
11. Mortality estimates by age and sex among persons living with HIV after ART initiation in Zambia using electronic medical records supplemented with tracing a sample of lost patients: A cohort study.
Kerkhoff AD; Sikombe K; Eshun-Wilson I; Sikazwe I; Glidden DV; Pry JM; Somwe P; Beres LK; Simbeza S; Mwamba C; Bukankala C; Hantuba C; Moore CB; Holmes CB; Padian N; Geng EH
PLoS Med; 2020 May; 17(5):e1003107. PubMed ID: 32401797
[TBL] [Abstract][Full Text] [Related]
12. Costs and Cost Effectiveness of Three Approaches for Cervical Cancer Screening among HIV-Positive Women in Johannesburg, South Africa.
Lince-Deroche N; Phiri J; Michelow P; Smith JS; Firnhaber C
PLoS One; 2015; 10(11):e0141969. PubMed ID: 26569487
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
[TBL] [Abstract][Full Text] [Related]
14. Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa.
Onoya D; Hirasen K; van den Berg L; Miot J; Long LC; Fox MP
Drug Saf; 2018 Dec; 41(12):1343-1353. PubMed ID: 30043384
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of high-risk human papillomavirus and cervical lesions in African women living with HIV/AIDS: effect of anti-retroviral therapy.
Kelly HA; Sawadogo B; Chikandiwa A; Segondy M; Gilham C; Lompo O; Omar T; Didelot MN; Nagot N; Meda N; Weiss HA; Delany-Moretlwe S; Mayaud P;
AIDS; 2017 Jan; 31(2):273-285. PubMed ID: 27755107
[TBL] [Abstract][Full Text] [Related]
16. Highly active antiretroviral therapy and cervical dysplasia in HIV-positive women in South Africa.
Firnhaber C; Westreich D; Schulze D; Williams S; Siminya M; Michelow P; Levin S; Faesen M; Smith JS
J Int AIDS Soc; 2012 Jun; 15(2):17382. PubMed ID: 22713259
[TBL] [Abstract][Full Text] [Related]
17. Modelling the impact of prevention strategies on cervical cancer incidence in South Africa.
van Schalkwyk C; Moodley J; Welte A; Johnson LF
Int J Cancer; 2021 Oct; 149(8):1564-1575. PubMed ID: 34164807
[TBL] [Abstract][Full Text] [Related]
18. Prospective One Year Follow Up of HIV Infected Women Screened for Cervical Cancer Using Visual Inspection with Acetic Acid, Cytology and Human Papillomavirus Testing in Johannesburg South Africa.
Firnhaber C; Goeieman B; Faesen M; Levin S; Williams S; Rameotshela S; Swarts A; Michelow P; Omar T; Williamson AL; Allan B; Schnippel K; Smith JS
PLoS One; 2016; 11(1):e0144905. PubMed ID: 26730710
[TBL] [Abstract][Full Text] [Related]
19. Impact of timing of antiretroviral therapy initiation on survival of cervical squamous intraepithelial lesions: a cohort analysis from South Africa.
Zeier MD; Nachega JB; Van Der Merwe FH; Eshun-Wilson I; Van Schalkwyk M; La Grange M; Mason D; Louw M; Botha MH
Int J STD AIDS; 2012 Dec; 23(12):890-6. PubMed ID: 23258831
[TBL] [Abstract][Full Text] [Related]
20. Comparing Papanicolau smear, visual inspection with acetic acid and human papillomavirus cervical cancer screening methods among HIV-positive women by immune status and antiretroviral therapy.
Chung MH; McKenzie KP; De Vuyst H; Richardson BA; Rana F; Pamnani R; Njoroge JW; Nyongesa-Malava E; Sakr SR; John-Stewart GC; Mugo NR
AIDS; 2013 Nov; 27(18):2909-19. PubMed ID: 23842133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
